Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCS + INAH vs INCS + OAH in Moderate to Severe Allergic Rhinitis
NCT07294326Phase 4Not yet recruiting
- Sponsor
- China-Japan Union Hospital of Jilin University
- Start
- Jan 2026
- Primary completion
- Oct 2026
01
Overview
Phase 4, randomised trial in allergic rhinitis (AR) (2 arms), sponsored by China-Japan Union Hospital of Jilin University. Primary endpoints: Total Nasal Symptom Score at 14 days, Total Ocular Symptom Score at 14 days and 2 more. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07294326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07294326.